NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

Search

Coloplast A-S (Class B)

Deschisă

578.4 0.7

Rezumat

Modificarea prețului

24h

Curent

Minim

569.8

Maxim

577.4

Indicatori cheie

By Trading Economics

Venit

-107M

805M

Vânzări

28M

7B

P/E

Medie Sector

35.437

106.172

EPS

3.88

Randament dividend

4.01

Marjă de profit

11.569

Angajați

16,744

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.01%

2.31%

Statistici piață

By TradingEconomics

Capitalizare de piață

-8B

129B

Deschiderea anterioară

577.7

Închiderea anterioară

578.4

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 nov. 2025, 23:36 UTC

Acțiuni populare

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 nov. 2025, 22:13 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 nov. 2025, 21:55 UTC

Principalele dinamici ale pieței

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 nov. 2025, 21:43 UTC

Achiziții, Fuziuni, Preluări

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 nov. 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 nov. 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 nov. 2025, 23:47 UTC

Câștiguri

Lenovo Group 2Q EPS $2.52 >0992.HK

19 nov. 2025, 23:46 UTC

Câștiguri

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 nov. 2025, 23:45 UTC

Câștiguri

Lenovo Group 2Q Rev $20.5B >0992.HK

19 nov. 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 nov. 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 nov. 2025, 23:41 UTC

Câștiguri

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 nov. 2025, 23:41 UTC

Câștiguri

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 nov. 2025, 23:40 UTC

Câștiguri

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 nov. 2025, 22:55 UTC

Câștiguri

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 nov. 2025, 22:41 UTC

Câștiguri

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 nov. 2025, 22:30 UTC

Achiziții, Fuziuni, Preluări

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 nov. 2025, 22:30 UTC

Câștiguri

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 nov. 2025, 22:30 UTC

Achiziții, Fuziuni, Preluări

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 nov. 2025, 22:27 UTC

Achiziții, Fuziuni, Preluări

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 nov. 2025, 22:08 UTC

Câștiguri

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 nov. 2025, 22:00 UTC

Câștiguri

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 nov. 2025, 21:58 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 nov. 2025, 21:52 UTC

Câștiguri

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 nov. 2025, 21:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

19 nov. 2025, 21:49 UTC

Market Talk
Câștiguri

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 nov. 2025, 21:38 UTC

Câștiguri

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 nov. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Palo Alto Networks to Buy Chronosphere for $3.35B

19 nov. 2025, 21:27 UTC

Achiziții, Fuziuni, Preluări

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 nov. 2025, 21:24 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat